297 related articles for article (PubMed ID: 30442205)
1. Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis.
Gryglewski G; Baldinger-Melich P; Seiger R; Godbersen GM; Michenthaler P; Klöbl M; Spurny B; Kautzky A; Vanicek T; Kasper S; Frey R; Lanzenberger R
Br J Psychiatry; 2019 Mar; 214(3):159-167. PubMed ID: 30442205
[TBL] [Abstract][Full Text] [Related]
2. Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition.
Hidalgo-Mazzei D; Berk M; Cipriani A; Cleare AJ; Florio AD; Dietch D; Geddes JR; Goodwin GM; Grunze H; Hayes JF; Jones I; Kasper S; Macritchie K; McAllister-Williams RH; Morriss R; Nayrouz S; Pappa S; Soares JC; Smith DJ; Suppes T; Talbot P; Vieta E; Watson S; Yatham LN; Young AH; Stokes PRA
Br J Psychiatry; 2019 Jan; 214(1):27-35. PubMed ID: 30520709
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.
Fabbri C; Kasper S; Kautzky A; Bartova L; Dold M; Zohar J; Souery D; Montgomery S; Albani D; Raimondi I; Dikeos D; Rujescu D; Uher R; Lewis CM; Mendlewicz J; Serretti A
Br J Psychiatry; 2019 Jan; 214(1):36-41. PubMed ID: 30468137
[TBL] [Abstract][Full Text] [Related]
4. Ketamine: stimulating antidepressant treatment?
Malhi GS; Byrow Y; Cassidy F; Cipriani A; Demyttenaere K; Frye MA; Gitlin M; Kennedy SH; Ketter TA; Lam RW; McShane R; Mitchell AJ; Ostacher MJ; Rizvi SJ; Thase ME; Tohen M
BJPsych Open; 2016 May; 2(3):e5-e9. PubMed ID: 27703782
[TBL] [Abstract][Full Text] [Related]
5. Volume of hippocampus-amygdala transition area predicts outcomes of electroconvulsive therapy in major depressive disorder: high accuracy validated in two independent cohorts.
Xu J; Li W; Bai T; Li J; Zhang J; Hu Q; Wang J; Tian Y; Wang K
Psychol Med; 2023 Jul; 53(10):4464-4473. PubMed ID: 35604047
[TBL] [Abstract][Full Text] [Related]
6. Grey Matter changes in treatment-resistant depression during electroconvulsive therapy.
Yrondi A; Nemmi F; Billoux S; Giron A; Sporer M; Taib S; Salles J; Pierre D; Thalamas C; Rigal E; Danet L; Pariente J; Schmitt L; Arbus C; Péran P
J Affect Disord; 2019 Nov; 258():42-49. PubMed ID: 31382103
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of brain structural changes after electroconvulsive therapy in depression.
Gryglewski G; Lanzenberger R; Silberbauer LR; Pacher D; Kasper S; Rupprecht R; Frey R; Baldinger-Melich P
Brain Stimul; 2021; 14(4):927-937. PubMed ID: 34119669
[TBL] [Abstract][Full Text] [Related]
8. Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression.
Joshi SH; Espinoza RT; Pirnia T; Shi J; Wang Y; Ayers B; Leaver A; Woods RP; Narr KL
Biol Psychiatry; 2016 Feb; 79(4):282-92. PubMed ID: 25842202
[TBL] [Abstract][Full Text] [Related]
9. Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study.
Cano M; Martínez-Zalacaín I; Bernabéu-Sanz Á; Contreras-Rodríguez O; Hernández-Ribas R; Via E; de Arriba-Arnau A; Gálvez V; Urretavizcaya M; Pujol J; Menchón JM; Cardoner N; Soriano-Mas C
Transl Psychiatry; 2017 Feb; 7(2):e1023. PubMed ID: 28170003
[TBL] [Abstract][Full Text] [Related]
10. Electroconvulsive therapy increases hippocampal and amygdala volume in therapy refractory depression: a longitudinal pilot study.
Tendolkar I; van Beek M; van Oostrom I; Mulder M; Janzing J; Voshaar RO; van Eijndhoven P
Psychiatry Res; 2013 Dec; 214(3):197-203. PubMed ID: 24090511
[TBL] [Abstract][Full Text] [Related]
11. Multiple-therapy-resistant major depressive disorder: a clinically important concept.
McAllister-Williams RH; Christmas DMB; Cleare AJ; Currie A; Gledhill J; Insole L; Malizia AL; McGeever M; Morriss R; Robinson LJ; Scott M; Stokes PRA; Talbot PS; Young AH
Br J Psychiatry; 2018 May; 212(5):274-278. PubMed ID: 30517072
[TBL] [Abstract][Full Text] [Related]
12. Bilateral ECT induces bilateral increases in regional cortical thickness.
van Eijndhoven P; Mulders P; Kwekkeboom L; van Oostrom I; van Beek M; Janzing J; Schene A; Tendolkar I
Transl Psychiatry; 2016 Aug; 6(8):e874. PubMed ID: 27552587
[TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive therapy increases temporal gray matter volume and cortical thickness.
Sartorius A; Demirakca T; Böhringer A; Clemm von Hohenberg C; Aksay SS; Bumb JM; Kranaster L; Ende G
Eur Neuropsychopharmacol; 2016 Mar; 26(3):506-17. PubMed ID: 26792445
[TBL] [Abstract][Full Text] [Related]
14. Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression.
Gbyl K; Rostrup E; Raghava JM; Andersen C; Rosenberg R; Larsson HBW; Videbech P
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110048. PubMed ID: 32730916
[TBL] [Abstract][Full Text] [Related]
15. Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorder.
Cao B; Luo Q; Fu Y; Du L; Qiu T; Yang X; Chen X; Chen Q; Soares JC; Cho RY; Zhang XY; Qiu H
Sci Rep; 2018 Apr; 8(1):5434. PubMed ID: 29615675
[TBL] [Abstract][Full Text] [Related]
16. Volume of the Human Hippocampus and Clinical Response Following Electroconvulsive Therapy.
Oltedal L; Narr KL; Abbott C; Anand A; Argyelan M; Bartsch H; Dannlowski U; Dols A; van Eijndhoven P; Emsell L; Erchinger VJ; Espinoza R; Hahn T; Hanson LG; Hellemann G; Jorgensen MB; Kessler U; Oudega ML; Paulson OB; Redlich R; Sienaert P; Stek ML; Tendolkar I; Vandenbulcke M; Oedegaard KJ; Dale AM
Biol Psychiatry; 2018 Oct; 84(8):574-581. PubMed ID: 30006199
[TBL] [Abstract][Full Text] [Related]
17. Exploring cortical predictors of clinical response to electroconvulsive therapy in major depression.
Schmitgen MM; Kubera KM; Depping MS; Nolte HM; Hirjak D; Hofer S; Hasenkamp JH; Seidl U; Stieltjes B; Maier-Hein KH; Sambataro F; Sartorius A; Thomann PA; Wolf RC
Eur Arch Psychiatry Clin Neurosci; 2020 Mar; 270(2):253-261. PubMed ID: 31278421
[TBL] [Abstract][Full Text] [Related]
18. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis.
Strawbridge R; Carter B; Marwood L; Bandelow B; Tsapekos D; Nikolova VL; Taylor R; Mantingh T; de Angel V; Patrick F; Cleare AJ; Young AH
Br J Psychiatry; 2019 Jan; 214(1):42-51. PubMed ID: 30457075
[TBL] [Abstract][Full Text] [Related]
19. Volumetric changes in subcortical structures following repeated ketamine treatment in patients with major depressive disorder: a longitudinal analysis.
Zhou YL; Wu FC; Liu WJ; Zheng W; Wang CY; Zhan YN; Lan XF; Ning YP
Transl Psychiatry; 2020 Aug; 10(1):264. PubMed ID: 32747631
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal effects of rTMS on neuroplasticity in chronic treatment-resistant depression.
Dalhuisen I; Ackermans E; Martens L; Mulders P; Bartholomeus J; de Bruijn A; Spijker J; van Eijndhoven P; Tendolkar I
Eur Arch Psychiatry Clin Neurosci; 2021 Feb; 271(1):39-47. PubMed ID: 32385741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
